Friday, April 29, 2016
Interventional Concepts, a CRO for innovative pharma, biotech and medtech development-stage companies proposing to conduct clinical trials in Colombia, and the Alliance for Clinical Research Excellence and Safety (ACRES), a multi-sector nonprofit operating in the public interest and committed to transforming the global clinical research environment, have announced a strategic alliance, joining Interventional Concepts with current ACRES Allies in their efforts to build ACRES’ shared global clinical research system.
WCCT Global, a full-service CRO, is announcing the opening of an office and clinical operations in Seoul, Korea. With the expansion of operations into South Korea, the company is poised to further establish itself as a global CRO. The expansion is a part of the company’s efforts to increase its capacity for conducting high quality clinical research in one of Asia’s fastest-growing countries for biopharmaceutical development.
Medrio, a Software as a Service (SaaS) company providing cloud-based data management capabilities to clinical researchers, and Clinartis, a CRO providing clinical trial services in the U.S. and Europe, have announced a new partnership under Medrio’s Partner Program. Clinartis and Medrio have cultivated a business relationship through numerous phase I studies for which the CRO has utilized Medrio’s flagship phase I-focused product, m1.
Charles River Laboratories International has entered into a strategic partnership with BioMotiv, the therapeutic accelerator company associated with The Harrington Project for Discovery & Development. Charles River will provide discovery and preclinical development services that will enable BioMotiv to advance discoveries sourced from academic research and non-governmental organizations into novel medicines.
InVentiv Health has filed paperwork for an initial public offering (IPO) worth up to $100 million, following in the footsteps of three other large private equity-backed CROs that have gone public in recent years. Analysts see strong financial activity on the horizon for the CRO industry.
Pharmaceutical and medical device teams plan to increasingly involve CROs in their clinical trial planning processes. The largest projected change is the level of vendor involvement in trial design activities, according to a recent report issued by pharmaceutical intelligence provider Cutting Edge Information.
Parexel International, a global biopharmaceutical services organization, and EMC have entered into an alliance to offer an end-to-end Regulatory Information Management (RIM) and Regulatory Content Management solution.